Our Program Focus
- Isotope Production—ensuring an adequate supply of medical isotopes.
- Advanced separation techniques for yttrium-90 from strontium-90, bismuth-212 from uranium-232 progeny, actinium-225 and bismuth-213 from thorium-229, radium-223 from actinium-227, and others.
- Radionuclide generators for bismuth-212 and bismuth-213.
- Reactor and accelerator targets using radium-226.
- Recovery and Recycle—enhancing our national security.
- Recovery of orphan radioactive sources for safeguarding and reuse, such as cobalt-60, cesium-137, radium-226, and strontium-90.
- Matching excess radioactive sources with end-users in need of those materials.
- Reprocessing and remanufacturing of radioisotope sources for special applications.
- Applications Research—identifying new chemistry solutions.
- Advanced radiochemical separations and automated systems.
- New drug and device design and testing.
- Client Technical Support—serving the special needs of our clients .
- External and internal radiation dosimetry, including medical internal dose for diagnostic and therapeutic radiopharmaceuticals.
- Animal biodistribution and dosimetry studies.
- Radioactive seed and restenosis stent development and testing.
- Cobalt-57 flood source development and manufacturing.
- Radioisotope generators and power sources.
